Back to Search
KEISHLA FIGUEROA, MD
MD
Pediatrics Physician
NPI: 1689254880Individual
Specialties, Licenses & Credentials
General Practice Physician
General Practice
Code: 208D00000X
16340I(PR)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
16340I(PR)
Research & Publications (20)
Profiling of dynamically changed gene expression in dorsal root ganglia post peripheral nerve injury and a critical role of injury-induced glial fibrillary acidic protein in maintenance of pain behaviors [corrected].
PMID 19307059·Pain·2009
7-preclinical
Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.
PMID 18824613·J Pharmacol Exp Ther·2009
7-preclinical
Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain.
PMID 18571852·Pain·2008
7-preclinical
Use of acetylcholine mustard to study allosteric interactions at the M(2) muscarinic receptor.
PMID 18682569·J Pharmacol Exp Ther·2008
7-preclinical
Effective proximity retrieval by ordering permutations.
PMID 18617721·IEEE Trans Pattern Anal Mach Intell·2008
8-other
Mitochondrial complex I gene variant associated with early age at onset in spinocerebellar ataxia type 2.
PMID 17620498·Arch Neurol·2007
8-other
3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide.
PMID 17684117·J Pharmacol Exp Ther·2007
4-observational
Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15.
PMID 17392404·J Pharmacol Exp Ther·2007
7-preclinical
Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.
PMID 16474416·Br J Pharmacol·2006
7-preclinical
Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.
PMID 16501573·Nat Genet·2006
7-preclinical
Generation and characterization of Sca2 (ataxin-2) knockout mice.
PMID 16293225·Biochem Biophys Res Commun·2006
7-preclinical
An autosomal dominant ataxia maps to 19q13: Allelic heterogeneity of SCA13 or novel locus?
PMID 16135769·Neurology·2005
8-other
Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
PMID 16000334·Brain·2005
8-other
Phenotypic variability associated with Arg26Gln mutation in caveolin3.
PMID 15318349·Muscle Nerve·2004
8-other
Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.
PMID 14514747·J Am Soc Nephrol·2003
3-trial
Identification and expression of the gene for human ataxin-2-related protein on chromosome 16.
PMID 14769358·Exp Neurol·2003
4-observational
Association of moderate polyglutamine tract expansions in the slow calcium-activated potassium channel type 3 with ataxia.
PMID 11594924·Arch Neurol·2001
4-observational
Rippling muscle disease: evidence for phenotypic and genetic heterogeneity.
PMID 11353417·Muscle Nerve·2001
5-case
Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.
PMID 10973246·Nat Genet·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 100 Ave Laurel
Bayamon, PR 00956 - Phone
- (787) 517-2482
Quick Facts
- NPI
- 1689254880
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile